This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Senate panel probes drug price hikes by Turing Valeant and others
A Senate aging committee seeks documents from Turing Pharmaceuticals Valeant Retrophin Inc and Rodelis Therapeutics as it presses for a face to face with CEO Martin Shkreli amid pricing spikes Daraprim rose over five thousand percent since acquisition and other drugs show sharp increases Retrophin faces questions over Thiola pricing and Rodelis over a tuberculosis drug price surge Dems push for hearings and subpoenas while Valeant stock slides amid broader pricing scrutiny
MENTIONED IN THIS ARTICLE
Washington
Senate
Turing Pharmaceuticals
Special Committee On Aging
Turing
Valeant Pharmaceuticals
Martin Shkreli
Shkreli
House of Representatives
Valeant
House Oversight Committee
Congress
U.S
Susan Collins
Rlaine
Claire McCaskill
D-Mo
Collins
McCaskill
Retrophin Inc
Rodelis Therapeutics
San Diego
Alpharetta
Retrophin
Rodelis
Ing Co
Quebec
Philidor Rx
Philidor